U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
CLAZAKIZUMAB
4S38Z8RA9O
Investigational
General
Names
9
Classification
1
Identifiers
10
Subunits
4
Related Substances
1
CLAZAKIZUMAB
4S38Z8RA9O
Investigational
General
Approval Year
Unknown
149,124
Names
9
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
CLAZAKIZUMAB
Official Name
English
ALD-518
Preferred Name
English
ALD518
Code
English
Clazakizumab [WHO-DD]
Common Name
English
CLAZAKIZUMAB (Aglycosylated IGG1 humanized rabbit antibody directed against IL6)
Common Name
English
Showing 1 to 5 of 9 entries
Previous
1
2
Next
Classification
1
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Treatment of chronic antibody-mediated rejection in kidney transplant recipients
FDA ORPHAN DRUG
612317
Showing 1 to 1 of 1 entries
Previous
1
Next
Identifiers
10
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
CAS
1236278-28-6
PRIMARY
INN
9599
PRIMARY
USAN
YY-119
PRIMARY
DRUG BANK
DB12849
PRIMARY
SMS_ID
100000142906
PRIMARY
Showing 1 to 5 of 10 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
4S38Z8RA9O
CLAZAKIZUMAB